Verdiana Ravarotto

Verdiana Ravarotto

Auto-generated profile, based on publicly available information

Verdiana Ravarotto

Division of Nephrology, Dialysis and Transplantation, Department of Medicine (DIMED), School of Medicine, University of Padova, Padova, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
VRVerdiana Ravarotto
Verdiana Ravarotto
GBGiovanni Bertoldi
Giovanni Bertoldi
LSLucia Federica Stefanelli
Lucia Federica Stefanelli
Federico NalessoFederico Nalesso
Federico Nalesso
LCLorenzo Calò
Lorenzo Calò
The high prevalence of cardiovascular disease in patients with chronic kidney disease indicates significant interactions between pathogenic pathways operating in the kidney and heart. These interactions involve all cell types (endothelial cells, smooth muscle cells, macrophages, and others), components of the vasculature, glomeruli, and heart that are susceptible to oxidative damage and structural alterations. A vicious cycle occurs whereby harmful factors such as reactive oxygen species and inflammation damage of vascular structures that themselves become sources of additional dangerous/toxic components released into the local environment. The evidence of this vicious cycle in chronic kidney disease should therefore lead to add other factors to both traditional and nontraditional risk factors. This review will examine the processes occurring during progressive kidney dysfunction with regard to vascular injury, renal remodeling, cardiac hypertrophy, and the transversal role of oxidative stress in the development of these complications.

1 April 2020 in Nutrition
Verified
Journal Article
Closed access
FFFrancesco Francini
Francesco Francini
VRVerdiana Ravarotto
Verdiana Ravarotto
GBGiovanni Bertoldi
Giovanni Bertoldi
PSPaolo Spinella
Paolo Spinella
LCLorenzo Calò
Lorenzo Calò

20 July 2022 in Kidney and Blood Pressure Research
Verified
Journal Article
Open access
PDF file
VRVerdiana Ravarotto
Verdiana Ravarotto
GBGiovanni Bertoldi
Giovanni Bertoldi
LSLucia Federica Stefanelli
Lucia Federica Stefanelli
Federico NalessoFederico Nalesso
Federico Nalesso
LCLorenzo A. Calò
Lorenzo A. Calò
Background: Gitelman’s and Bartter’s syndromes (GS/BS) are rare genetic tubulopathies characterized by electrolyte imbalance and activation of the renin-angiotensin-aldosterone system (RAAS). These syndromes have intriguing biochemical and hormonal abnormalities that lead them to be protected from hypertension and cardiovascular and renal remodeling. Summary: In this review, we explore the biochemical/molecular mechanisms induced by the activation of the RAAS and its counterregulatory arm which is particularly activated in GS/BS patients, in the context of blood pressure regulation. In addition, we report our findings in the context of the COVID-19 pandemic where we observed GS/BS subjects being protected from infection. Key Messages: The intracellular pathways induced by Ang II, starting from induction of oxidative stress and vasoconstriction, are crucial for the progression toward cardiovascular-renal remodeling and might be useful targets in order to reduce/halt the progression of Ang II/oxidative stress-induced cardiovascular-renal morbidity in several diseases.